Keywords: new, data, idenix, telbivudine, promising, one-year, phase

New data for Idenix' telbivudine

Article | 26 April 2004

Print This

Promising one-year data from a Phase IIb trial of Idenix Pharmaceuticals' antiviral telbivudine were reported at the annual meeting of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in